OpenExamsFREE PRACTICE — ANY EXAM

Montana Pharmacist — Requirements & Free Practice

US-MT · License preparation

850 free questions · Answer explanations · No signup required

Choose what to practice

Start with an exam below. Your examination requirements depend on your application pathway. View licensing requirements

Combined practice

Choose an exam or combined practice to begin.

Licenses, application pathways and examination requirements

Each license and applicant pathway has its own requirements and exemptions. Choosing practice questions does not determine your eligibility.

Pharmacist

Montana pharmacist license issued by the Board of Pharmacy under MCA Title 37, chapter 7.

Licensing authority: Montana Board of Pharmacy · Application information

Licensure by examination (U.S. accredited pharmacy graduate)
Discontinued Examination
The Montana state-specific MPJE named by ARM 24.174.501(2)/24.174.502(3) and the Board materials was retired by NABP for Montana on May 31, 2026 and replaced by the Uniform MPJE from June 1, 2026; the retired examination is omitted and the UMPJE leaf carries the jurisprudence requirement.
Education
Graduated with the first professional degree from the University of Montana-Missoula school of pharmacy or holds an accredited pharmacy degree approved by the Board (MCA 37-7-302(1)); the Board application names graduation from an ACPE-accredited school and a Certificate of Pharmacy Education.
Good Moral Character
Must be of good moral character (MCA 37-7-302(1)).
Internship
Must complete the Board internship requirement, 1500 documented intern hours (MCA 37-7-302(1); ARM 24.174.602; Board application item 1.c).
Jurisprudence Passing Score
A jurisprudence examination score of not less than 75 is passing; retake after a 30-day waiting period (ARM 24.174.501(2)).
Naplex Passing Score
A NAPLEX score of 75 is passing; retakes follow NABP requirements (ARM 24.174.501(1)).
Licensure by examination (foreign pharmacy graduate)
Discontinued Examination
The Montana state-specific MPJE named by ARM 24.174.501(2)/24.174.502(3) and the Board materials was retired by NABP for Montana on May 31, 2026 and replaced by the Uniform MPJE from June 1, 2026; the retired examination is omitted and the UMPJE leaf carries the jurisprudence requirement.
Foreign Graduate
Pharmacy graduate from outside the 50 states, the District of Columbia or Puerto Rico seeking certification of educational equivalency (ARM 24.174.501(3)).
Fpgec Certification
Must receive NABP FPGEC Certification, which includes the FPGEE, the Test of Spoken English (TSE) and the Test of English as a Foreign Language (TOEFL); NABP minimum passing scores must be achieved on all tests and examinations (ARM 24.174.501(3)-(4)). TSE and TOEFL are language proficiency tests, recorded here as conditions.
Good Moral Character
Must be of good moral character (MCA 37-7-302(1)).
Internship
1500 hours of internship in the United States (ARM 24.174.501(3)(b)).
Interview
Interview before the Board of Pharmacy or its designee (ARM 24.174.501(3)(a)).
Passing Scores
NAPLEX passing score 75; jurisprudence examination passing score not less than 75 (ARM 24.174.501(1)-(2)).
Licensure by transfer from another state (NAPLEX licensed applicant)
Completion Window
The licensure process must be completed within one year of the NABP application (ARM 24.174.502(4)).
Discontinued Examination
The Montana state-specific MPJE named by ARM 24.174.501(2)/24.174.502(3) and the Board materials was retired by NABP for Montana on May 31, 2026 and replaced by the Uniform MPJE from June 1, 2026; the retired examination is omitted and the UMPJE leaf carries the jurisprudence requirement.
Jurisprudence Score Transfer
NABP (exam owner) states for Montana under "UMPJE Required for Licensure Transfer": "Must have a previous passing UMPJE or MPJE score in any jurisdiction." A passing MPJE score from another jurisdiction is that jurisdiction's examination and is accepted per NABP; ARM 24.174.502(3) itself requires passing the MPJE (now the UMPJE for Montana).
Licensed Elsewhere
Licensed by another state after taking the NAPLEX; verification of current licensure in good standing from all other states where licensed (ARM 24.174.502(1)(c)).
Nabp Transfer Application
NABP transfer of licensure application (e-LTP) and appropriate fees (ARM 24.174.502(1)(a),(d)).
Naplex Score
Proof of a passing NAPLEX score (ARM 24.174.502(1)(b)).
Substantial Equivalency
Applicants for licensure by endorsement must hold an active license in good standing from a jurisdiction whose qualifications are substantially equivalent (MCA 37-1-304(1)); ARM 24.174.511 (adopted effective 2025-12-06) incorporates the Board's substantial equivalency list.
Licensure by transfer from another state (licensed by examination without the NAPLEX)

All of the following:

Board Appearance
Must appear before the Board for consideration of transfer of licensure (ARM 24.174.502(2)).
Completion Window
The licensure process must be completed within one year of the NABP application (ARM 24.174.502(4)).
Discontinued Examination
The Montana state-specific MPJE named by ARM 24.174.501(2)/24.174.502(3) and the Board materials was retired by NABP for Montana on May 31, 2026 and replaced by the Uniform MPJE from June 1, 2026; the retired examination is omitted and the UMPJE leaf carries the jurisprudence requirement.
Jurisprudence Score Transfer
NABP (exam owner) states for Montana under "UMPJE Required for Licensure Transfer": "Must have a previous passing UMPJE or MPJE score in any jurisdiction." A passing MPJE score from another jurisdiction is that jurisdiction's examination and is accepted per NABP; ARM 24.174.502(3) itself requires passing the MPJE (now the UMPJE for Montana).
Licensed Elsewhere
Registered as a pharmacist by examination in another state without having taken the NAPLEX; verification of current licensure in good standing from all other states where licensed (ARM 24.174.502(2)(c)).
Prior Examination Score
Proof of a passing score on the examination by which the applicant was licensed in the other state (ARM 24.174.502(2)(b)); that examination is prior evidence, not a leaf.
Substantial Equivalency
Active license in good standing from a substantially equivalent jurisdiction (MCA 37-1-304(1)).
Transfer Application
Transfer of licensure application and appropriate fees (ARM 24.174.502(2)(a),(d)).

Foreign Pharmacy Graduate Equivalency Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
200 questions
Time limit
4.5 hours examination time; 5.5 hours total seat time
Passing score
Scaled score of 75
Examination outline
  • Foundational Biomedical Sciences (12%)
    • Anatomy and physiology
    • Biochemistry
    • Medical microbiology
    • Immunology
    • Pathophysiological bases of diseases
  • Pharmaceutical Sciences (31%)
    • Pharmaceutical calculations (eg, dose adjustments, delivery, ionization, ionic strength, isotonicity, ratio/percentage strength, osmolarity)
    • Medicinal chemistry
    • Medicinal chemistry: Physicochemical properties of drugs in relation to drug absorption, distribution, metabolism, and excretion (ADME)
    • Medicinal chemistry: Pathways of drug metabolism
    • Medicinal chemistry: Chemical bases for drug action, including bioorganic chemistry, structure-activity relationships, and fundamental pharmacophores related to drug-receptor interactions
    • Medicinal chemistry: Applicability to making drug therapy decisions
    • Pharmacology and toxicology
    • Pharmacology and toxicology: Pharmacodynamics, including drug-receptor interactions, agonists, antagonists, inverse agonists, and dose-response curves
    • Pharmacology and toxicology: Mechanisms of action of drugs, including biologics
    • Pharmacology and toxicology: Adverse effects and side effects of drugs
    • Pharmacology and toxicology: Mechanisms of drug interactions, including drug-drug, drug-disease, drug-food, drug-allergy, and drug-laboratory interactions
    • Pharmacology and toxicology: Mechanisms of acute and chronic toxic effects of xenobiotics, including drug and chemical overdose or exposure and antidotes
    • Pharmaceutics and biopharmaceutics
    • Pharmaceutics and biopharmaceutics: Dosage form development and drug delivery systems such as immediate release, sustained release, and controlled release
    • Pharmaceutics and biopharmaceutics: Disintegration and dissolution of solid oral dosage forms
    • Pharmaceutics and biopharmaceutics: Physicochemical properties of drugs, excipients, solutions, and dosage forms
    • Pharmaceutics and biopharmaceutics: Physical stability, chemical stability, and shelf-lives, including zero-, first-, second-, and pseudo-order reactions
    • Pharmaceutics and biopharmaceutics: Interactions between drug formulation and biological effects
    • Pharmaceutics and biopharmaceutics: Drug product manufacturing, including methods, processing, and quality assurance
    • Pharmacokinetics
    • Pharmacokinetics: Determining rates of absorption, distribution, metabolism, and excretion (ADME) of drugs
    • Pharmacokinetics: Factors affecting rates of ADME, including age, sex, genetics, diet, disease, and drug interactions
    • Pharmacokinetics: Biological half-lives of drugs and related dosing
    • Pharmacokinetics: Compartment models (one-, two-, and non-)
    • Pharmacokinetics: Linear and nonlinear pharmacokinetics
    • Pharmacokinetics: Principles of bioavailability, bioequivalence, and biosimilars
    • Pharmacogenomics (eg, population-based genetic influences on drug metabolism and efficacy, genetic testing, tumor genotyping, pharmacogenetic screening)
    • Extemporaneous compounding (eg, United States Pharmacopeia (USP) standards including Chapters <795>, <797>, and <800>; dosage form preparation calculations; techniques used to prepare and dispense sterile and nonsterile preparations)
  • Social, Behavioral, and Administrative Sciences (20%)
    • Pharmacy law and ethics
    • Pharmacy law and ethics: Laws and regulations governing pharmacy
    • Pharmacy law and ethics: Regulatory, oversight, and professional organizations
    • Pharmacy law and ethics: Principles and application of biomedical ethics
    • Health care systems
    • Health care systems: Organization, regulation, and financing of health care delivery in the United States
    • Health care systems: Factors that influence delivery and use of health care (eg, social, political, economic, and technological)
    • Pharmacoeconomics (eg, analysis, interpretation, application, humanistic outcomes)
    • Population-based care, pharmacoepidemiology, and public health
    • Population-based care, pharmacoepidemiology, and public health: Data sources and analytic tools
    • Population-based care, pharmacoepidemiology, and public health: Application of epidemiological study design
    • Population-based care, pharmacoepidemiology, and public health: Health promotion, disease prevention, and infection control
    • Population-based care, pharmacoepidemiology, and public health: Continuous quality improvement
    • Population-based care, pharmacoepidemiology, and public health: Social determinants and drivers of health
    • Practice management
    • Practice management: Financial management and budgeting
    • Practice management: Personnel management
    • Practice management: Business and strategic planning
    • Practice management: Risk management
    • Practice management: Procurement and inventory control
    • Professional communication
    • Professional communication: Verbal, nonverbal, written, and technology-based communication with patients, caregivers, providers, and stakeholders
    • Professional communication: Health literacy
    • Biostatistics and research methods (eg, study design, statistical tests, data collection instruments, research ethics)
    • Social and behavioral aspects of practice
    • Social and behavioral aspects of practice: Patient behavior including health-, illness-, and sick-role
    • Social and behavioral aspects of practice: Principles of behavior modification
    • Social and behavioral aspects of practice: Patient adherence
    • Social and behavioral aspects of practice: Cultural awareness
  • Pharmacy Practice and Clinical Sciences (37%)
    • Clinical pathophysiology as it applies to treatment of disease processes
    • Data collection (eg, patient history, physical assessments, laboratory values, point-of-care testing)
    • Data assessment (eg, clinical calculations, interpretation of data, diagnosing)
    • Patient-care decision making, therapy recommendations, and education (eg, plan, implement, monitor, follow-up)
    • Patient safety (eg, drug interactions, toxicity, drug-induced disease, drug use disorders)
    • Disease prevention (eg, screenings, immunization, non-pharmacological therapies, lifestyle modifications)
    • Personalized medicine (eg, pharmacokinetics, pharmacogenetics)
    • Evidence-based practice
    • Evidence-based practice: Practice guidelines
    • Evidence-based practice: Drug information and evaluation
    • Evidence-based practice: Information source reliability
    • Evidence-based practice: Clinical trial evaluation
    • Self-care, including using natural products
Examination sources

North American Pharmacist Licensure Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
225 questions
Time limit
6 hours
Passing score
Pass or Fail
Examination outline
  • Foundational Knowledge for Pharmacy Practice (25%)
    • Pharmaceutical science principles and concepts
    • Pharmaceutical science principles and concepts: Pharmacology
    • Pharmaceutical science principles and concepts: Pharmacokinetics, pharmacodynamics, or pharmacogenomics
    • Pharmaceutical science principles and concepts: Pharmaceutics
    • Pharmaceutical compounding
    • Pharmaceutical compounding: Nonsterile preparations
    • Pharmaceutical compounding: Sterile preparations
    • Pharmaceutical calculations
    • Pharmaceutical calculations: Patient parameters or laboratory measures
    • Pharmaceutical calculations: Quantities of drugs to be dispensed or administered
    • Pharmaceutical calculations: Rates of administration
    • Pharmaceutical calculations: Dose conversions
    • Pharmaceutical calculations: Drug concentrations, ratio strengths, osmolarity, or osmolality
    • Pharmaceutical calculations: Quantities of drugs or ingredients to be compounded
    • Pharmaceutical calculations: Nutritional needs and the content of nutrient sources
    • Pharmaceutical calculations: Biostatistical, epidemiological, or pharmacoeconomic measures
    • Pharmaceutical calculations: Pharmacokinetic parameters
    • Drug development processes (eg, clinical trial phases, emergency use authorizations)
    • Research design principles and biostatistics (eg, blinding, randomization, biases, statistical tests and outcomes, ethics)
    • Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (25%)
    • Prescriptions and medication order interpretation
    • Prescriptions and medication order interpretation: Drug names and therapeutic classes
    • Prescriptions and medication order interpretation: Indications, usage, and dosing regimens
    • Prescriptions and medication order interpretation: Available dosage forms
    • Prescriptions and medication order interpretation: Prescription regulations (eg, boxed warnings, risk evaluation and mitigation strategies)
    • Prescriptions and medication order interpretation: Safety and effectiveness (eg, laboratory parameters, vital signs)
    • Therapeutic substitutions (eg, formulary restrictions, therapeutic alternatives, shortages, biosimilars)
    • Immunization services and documentation
    • Immunization services and documentation: Indications and scheduling
    • Immunization services and documentation: Contraindications and precautions
    • Immunization services and documentation: Storage and handling
    • Immunization services and documentation: Administration (eg, techniques, preparation, routes)
    • Immunization services and documentation: Adverse reactions
    • Medication handling, storage, stability, and disposal (eg, hazardous and nonhazardous drugs, controlled substances, parenteral medications, sharps handling, temperature control)
  • Person-Centered Assessment and Treatment Planning (40%)
    • Medication history, allergy history, and reconciliation
    • Health histories, screenings, and assessments
    • Patient health conditions, including special populations and medication-related factors
    • Patient health conditions, including special populations and medication-related factors: Signs, symptoms, and findings of medical conditions, etiology of diseases, or pathophysiology
    • Patient health conditions, including special populations and medication-related factors: Appropriateness of therapy (eg, medications, immunizations, non-drug therapy, dosing, contraindications, warnings, evidence-based decision making)
    • Patient health conditions, including special populations and medication-related factors: Interactions (eg, drug-drug, drug-condition, drug-food, drug-allergy, drug-laboratory)
    • Patient health conditions, including special populations and medication-related factors: Errors and omissions (eg, dosing, duplication, additional therapy needed, unnecessary therapy)
    • Patient health conditions, including special populations and medication-related factors: Adverse drug reactions
    • Patient health conditions, including special populations and medication-related factors: Toxicologic exposures and overdoses
    • Patient health conditions, including special populations and medication-related factors: Adherence
    • Therapeutic monitoring, plan development, evaluation, and modifications
    • Therapeutic monitoring, plan development, evaluation, and modifications: Therapeutic goals, clinical endpoints, and follow-up
    • Therapeutic monitoring, plan development, evaluation, and modifications: Safety
    • Therapeutic monitoring, plan development, evaluation, and modifications: Effectiveness
    • Patient education
    • Patient education: Lifestyle modifications and health maintenance
    • Patient education: Medication use, storage, and disposal
    • Patient education: Disease state management
    • Over-the-counter medications and dietary supplements
    • Devices to administer medications and self-monitoring tests
  • Professional Practice (5%)
    • Adverse drug event reporting and medication error reporting (eg, MedWatch, VAERS)
    • Public health initiatives and risk-prevention programs (eg, tobacco and nicotine cessation, antimicrobial stewardship, health screenings, opioid stewardship)
    • Social determinants and drivers of health
    • Ethical considerations (eg, informed consent, ethical principles, professional conduct and responsibility, patient confidentiality)
  • Pharmacy Management and Leadership (5%)
    • Pharmacy operations (eg, operational planning, risk management, regulations and regulatory bodies, technology applications and informatics, error-prevention strategies, medication safety)
    • Inventory and supply management (eg, drug recalls, drug shortages)
    • Quality improvement activities (eg, medication use evaluation, root-cause analysis, continuous quality improvement)
    • Mentorship and preceptorship (eg, providing and receiving feedback, delegation of work activities, preceptor roles)
Examination sources

Uniform MPJE

Provider
National Association of Boards of Pharmacy
Format
Computer-based adaptive selected-response examination
Exam questions
120 questions
Time limit
2.5 hours
Passing score
Pass or Fail
Examination outline
  • Pharmacy and Pharmacist Practice (30%)
    • Practice of pharmacy definition (eg, scope of authority, scope of practice, collaborative practice agreements and other delegative authorities, limitations or restrictions on practice)
    • Non-pharmacist personnel (eg, supervision, scope, licensure, counseling)
    • Adulterated or misbranded medications (eg, medication recalls, expiration dates, counterfeit medications, emergency use authorizations, importation, Drug Supply Chain Security Act (DSCSA))
    • Federal regulatory standards (eg, National Institute for Occupational Safety and Health (NIOSH), Occupational Safety and Health Administration (OSHA), essential copies of commercial products, patient-specific prescription requirements, anticipatory compounding)
    • United States Pharmacopeia (USP) standards on compounding and hazardous materials (eg, beyond-use dating, competency training, environmental testing, record keeping)
    • Security of patient health information
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (30%)
    • Requirements for issuing prescriptions and medication orders, including controlled substances
    • Requirements for issuing prescriptions and medication orders, including controlled substances: Validity of a prescription (eg, authority, content, corresponding responsibility)
    • Requirements for issuing prescriptions and medication orders, including controlled substances: Changes to a prescription
    • Requirements for issuing prescriptions and medication orders, including controlled substances: Emergency prescriptions and emergency refills
    • Dispensing medications, including controlled substances
    • Dispensing medications, including controlled substances: Pharmacy and manufacturer labeling, including over-the-counter medications and patient education
    • Dispensing medications, including controlled substances: Drug utilization review
    • Dispensing medications, including controlled substances: Fills, refills, and partial fills
    • Dispensing medications, including controlled substances: Packaging and repackaging
    • Dispensing medications, including controlled substances: Counseling
    • Dispensing medications, including controlled substances: Transfers
    • Dispensing medications, including controlled substances: Prescription drug monitoring program (PDMP) requirements
    • Dispensing medications, including controlled substances: Recalls, returns, and reuse
    • Dispensing medications, including controlled substances: Drug product selection (eg, substitutions, interchangeability)
    • Administration of medications, including adverse event reporting
  • Regulatory Authority and Legal Obligations (20%)
    • Role of regulatory authorities, including authority, inspections, and discipline
    • Role of regulatory authorities, including authority, inspections, and discipline: Federal (eg, Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), US Department of Health and Human Services (HHS))
    • Role of regulatory authorities, including authority, inspections, and discipline: State (eg, board of pharmacy, department of health)
    • Controlled substances
    • Controlled substances: Inventory
    • Controlled substances: Record keeping
    • Controlled substances: Order forms and ordering
    • Controlled substances: DEA registration and power of attorney
    • Controlled substances: Theft and loss
    • Controlled substances: Disposal
    • Liability and malpractice
  • Pharmacy Operations (20%)
    • Licensures, registrations, and certifications
    • Pharmacy technology, including record keeping and automation (eg, e-prescribing, faxing, shared services)
    • Access, storage, handling, and security
Examination sources